A Novel Therapy for ALS: Allogeneic Schwann Cell Extracellular Vesicles
Goldschmidt, P. J.; Khan, A.; Guest, J. D.; Jimsheleishvili, G.; Graham, P.; Brooks, A. E.; Silvera, R.; Goldschmidt, A. J.; Pearse, D. D.; Dietrich, D. W.; Levi, A. D.
Show abstract
Amyotrophic Lateral Sclerosis (ALS) is a terminal condition with accelerated loss of motor neurons (MN), resulting in the progressive paralysis of affected patients. ALS is either sporadic (90%) or genetically transmitted (10%) and affects cortical (pyramidal) and spinal cord (lower) MN, axons, and respective muscle endplates. ALS research has focused on MN survival, and current FDA-approved therapies provide only small patient survival benefits. This study reports the intravenous (IV) delivery of serial infusions of allogenic Schwann cell-derived extracellular vesicles (SCEV). The recipient had transient clinical stabilization during treatment but deteriorated rapidly during a pause in the infusions. There were no SCEV infusion-related adverse events observed. Allogeneic SCEV appeared safe for IV delivery in this case and may have therapeutic potential.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The Impact of Brain-Derived Neurotrophic Factor rs6265 (Val66Met) Polymorphism on Therapeutic Electrical Stimulation for Peripheral Nerve Regeneration: A Preclinical Study of Therapy-Genotype Interactions 91%
- Multipoint Stimulation Motor Unit Number Estimation of the Extensor Indicis and Anconeus after Cervical Spinal Cord Injury 91%
- Mitochondrial genome variants associated with Amyotrophic Lateral Sclerosis and their haplogroup distribution 90%
Similar papers in this journal
- RAN translation of C9orf72-related dipeptide repeat proteins in zebrafish recapitulates hallmarks of amyotrophic lateral sclerosis and identifies hypothermia as a therapeutic strategy 91%
- Elevated plasma phosphorylated tau 181 in amyotrophic lateral sclerosis relates to lower motor neuron dysfunction 91%
- Long term follow-up in anti-contactin-1 autoimmune nodopathy 91%
Similar papers in this journal
- The oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling, and therapeutic implications 90%
- Spinal Cord Motor Neuron Phenotypes and Polygenic Risk Scores in Sporadic Amyotrophic Lateral Sclerosis: Deciphering the Disease Pathology and Therapeutic Potential of Ropinirole Hydrochloride 89%
- Low lymphocyte count is a risk factor for Parkinsons disease 89%
Similar papers in this journal
- Nusinersen in adult patients with 5q spinal muscular atrophy: a multicenter observational cohorts’ study 93%
- Peripherin: a novel early diagnostic and prognostic plasmatic biomarker in Amyotrophic Lateral Sclerosis 93%
- Muscle microRNAs in the cerebrospinal fluid predict clinical response to nusinersen therapy in type II and type III spinal muscular atrophy patients 90%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.